T1	CHEM 1 30	Interferón gamma recombinante
#1	AnnotatorNotes T1	C3539881; gamma-interferon; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
T2	DISO 383 395	intolerantes
#2	AnnotatorNotes T2	C0277585; Intolerance to drug; Pathologic Function
T3	DISO 73 100	artritis idiopática juvenil
#3	AnnotatorNotes T3	C3495559; Juvenile arthritis; Disease or Syndrome
T4	DISO 120 147	artritis idiopática juvenil
#4	AnnotatorNotes T4	C3495559; Juvenile arthritis; Disease or Syndrome
T5	DISO 149 152	AIJ
#5	AnnotatorNotes T5	C3495559; Juvenile arthritis; Disease or Syndrome
T6	DISO 161 184	enfermedad del colágeno
#6	AnnotatorNotes T6	C0009326; Collagen Diseases; Disease or Syndrome
T7	DISO 203 220	sinovitis crónica
#7	AnnotatorNotes T7	C0877521; Chronic synovitis; Disease or Syndrome
T8	DISO 223 248	síntomas extraarticulares
T9	CHEM 293 309	interferón gamma
#8	AnnotatorNotes T9	C3539881; gamma-interferon; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
T10	PROC 408 416	terapias
#9	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	PROC 452 483	evaluar su eficacia y seguridad
#10	AnnotatorNotes T11	C0511730; Identify product efficacy and safety issues; Health Care Activity
T12	CHEM 489 500	medicamento
#11	AnnotatorNotes T12	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T13	DISO 537 547	enfermedad
#12	AnnotatorNotes T13	C0012634; Disease; Disease or Syndrome
T14	PROC 574 611	ensayo clínico abierto, no controlado
#13	AnnotatorNotes T14	C0681868; Uncontrolled Study; Research Activity + C1709323; Open Label Study; Research Activity
T15	CHEM 1288 1292	INFγ
#14	AnnotatorNotes T15	C3539881; gamma-interferon; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
T16	DISO 768 771	AIJ
#15	AnnotatorNotes T16	C3495559; Juvenile arthritis; Disease or Syndrome
T17	PROC 873 884	tratamiento
#16	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	ANAT 952 966	articulaciones
#17	AnnotatorNotes T18	C0022417; Joints; Body Space or Junction | C1269611; Entire joint; Body Space or Junction
T19	DISO 982 1001	síntomas sistémicos
T20	PROC 1008 1038	valores de eritrosedimentación
#18	AnnotatorNotes T20	C1176468; Erythrocyte sedimentation rate measurement; Laboratory Procedure
T21	PROC 1045 1068	cuestionario de calidad
T22	CHEM 1171 1181	esteroides
#19	AnnotatorNotes T22	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T23	PROC 1214 1225	tratamiento
#20	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	DISO 1383 1393	enfermedad
#21	AnnotatorNotes T24	C0012634; Disease; Disease or Syndrome
T25	CHEM 1424 1432	citocina
#22	AnnotatorNotes T25	C0079189; cytokine; Amino Acid, Peptide, or Protein · Immunologic Factor
T26	DISO 1495 1498	AIJ
#23	AnnotatorNotes T26	C3495559; Juvenile arthritis; Disease or Syndrome
T27	PROC 1530 1550	estudios controlados
#24	AnnotatorNotes T27	C0681867; Controlled Study; Research Activity
T28	CHEM 637 641	INFγ
#25	AnnotatorNotes T28	C3539881; gamma-interferon; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
T29	CHEM 176 184	colágeno
#26	AnnotatorNotes T29	C0009325; collagen; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T30	CHEM 311 315	INFγ
#27	AnnotatorNotes T30	C3539881; gamma-interferon; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
T31	CHEM 1322 1338	quimiocina CCR-4
#28	AnnotatorNotes T31	C0539692; Receptors, CCR4; Amino Acid, Peptide, or Protein · Receptor
T32	LIVB 63 68	niños
#29	AnnotatorNotes T32	C0008059; Child; Age Group
T33	Duration 213 220	crónica
#30	AnnotatorNotes T33	C0205191; chronic; Temporal Concept
T34	Age 273 280	16 años
T35	LIVB 359 368	pacientes
#31	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T37	Route 646 663	vía intramuscular
#32	AnnotatorNotes T37	C1556154; Intramuscular Route of Drug Administration; Functional Concept
T38	Dose 676 707	50 000 UI/kg (hasta 1 x 106 UI)
T40	Duration 716 722	2 años
T41	LIVB 754 763	pacientes
#33	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	LIVB 889 898	pacientes
#34	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	LIVB 1136 1145	pacientes
#35	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T45	LIVB 1258 1267	pacientes
#36	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	LIVB 1346 1351	niños
#37	AnnotatorNotes T46	C0008059; Child; Age Group
T47	Neg_cue 1358 1360	no
T48	LIVB 1368 1375	adultos
#38	AnnotatorNotes T48	C0001675; Adult; Age Group
T51	LIVB 1481 1490	pacientes
#39	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
A1	Population_data T32 Age
A3	Population_data T46 Age
A4	Population_data T48 Age
R1	Negation Arg1:T47 Arg2:T48	
R2	Experiences Arg1:T48 Arg2:T24	
T36	Neg_cue 598 600	no
T49	Quantifier_or_Qualifier 601 611	controlado
A5	Assertion T49 Negated
R3	Negation Arg1:T36 Arg2:T49	
R4	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T49	
T50	Spec_cue 1433 1438	puede
T52	CONC 1447 1458	alternativa
A6	Assertion T52 Speculated
#40	AnnotatorNotes T52	C1523987;Alternative; Qualitative Concept
T53	Quantifier_or_Qualifier 1471 1477	eficaz
A7	Assertion T53 Speculated
#41	AnnotatorNotes T53	C1704419; Effective; Qualitative Concept
R6	Has_Quantifier_or_Qualifier Arg1:T52 Arg2:T53	
R7	Speculation Arg1:T50 Arg2:T52	
R8	Speculation Arg1:T50 Arg2:T53	
R5	Experiences Arg1:T32 Arg2:T1	
R9	Experiences Arg1:T32 Arg2:T3	
R10	Causes Arg1:T4 Arg2:T7	
R11	Has_Duration_or_Interval Arg1:T7 Arg2:T33	
R12	Causes Arg1:T5 Arg2:T7	
R13	Causes Arg1:T5 Arg2:T8	
R14	Causes Arg1:T4 Arg2:T8	
R15	Before Arg1:T4 Arg2:T34	
R16	Before Arg1:T5 Arg2:T34	
R17	Experiences Arg1:T35 Arg2:T2	
R18	Experiences Arg1:T35 Arg2:T10	
R19	Experiences Arg1:T35 Arg2:T30	
R20	Experiences Arg1:T35 Arg2:T9	
T44	Observation 369 380	resistentes
#42	AnnotatorNotes T44	C3542449; Drug Resistance Status; Finding (?)
R21	Experiences Arg1:T35 Arg2:T44	
R22	Causes Arg1:T10 Arg2:T2	
R23	Overlap Arg1:T44 Arg2:T10	
R25	Experiences Arg1:T35 Arg2:T13	
R24	Has_Route_or_Mode Arg1:T28 Arg2:T37	
R27	Has_Dose_or_Strength Arg1:T28 Arg2:T38	
R29	Has_Duration_or_Interval Arg1:T28 Arg2:T40	
R30	Experiences Arg1:T41 Arg2:T16	
T54	Quantifier_or_Qualifier 835 844	sistémica
#43	AnnotatorNotes T54	C0205373; Systemic; Functional Concept
T55	Quantifier_or_Qualifier 813 826	poliarticular
#44	AnnotatorNotes T55	C0240789; Polyarticular; Qualitative Concept
T56	Quantifier_or_Qualifier 791 805	pauciarticular
#45	AnnotatorNotes T56	C0439754; Oligoarticular; Spatial Concept
R31	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T56	
R32	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T55	
R33	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T54	
T57	CONC 863 884	final del tratamiento
R34	Experiences Arg1:T42 Arg2:T17	
T58	Observation 924 937	respondedores
#46	AnnotatorNotes T58	C0919876; Therapy responder; Finding
R35	Experiences Arg1:T42 Arg2:T58	
R36	Overlap Arg1:T58 Arg2:T57	
T59	Observation 942 976	número de articulaciones afectadas
R37	Location_of Arg1:T18 Arg2:T59	
R38	Experiences Arg1:T43 Arg2:T22	
T62	CONC 1195 1200	dosis
#49	AnnotatorNotes T62	C0178602; Dosage; Quantitative Concept
R39	Used_for Arg1:T62 Arg2:T22	
T63	Observation 1230 1243	bien tolerado
R40	Overlap Arg1:T23 Arg2:T63	
R41	Experiences Arg1:T45 Arg2:T63	
R42	Experiences Arg1:T45 Arg2:T23	
R44	Experiences Arg1:T46 Arg2:T15	
R45	Experiences Arg1:T46 Arg2:T24	
R46	Experiences Arg1:T48 Arg2:T15	
R47	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T52	
R48	Experiences Arg1:T51 Arg2:T25	
R49	Experiences Arg1:T51 Arg2:T26	
R26	Experiences Arg1:T35 Arg2:T12	
#51	AnnotatorNotes T63	C5684674; patient tolerated procedure well; Finding
#47	AnnotatorNotes T49	C4553389; Study Control; Conceptual Entity
#48	AnnotatorNotes T59	C0422808; Number of joints involved; Finding
A2	Experiencer T32 Patient
A8	Experiencer T35 Patient
A9	Experiencer T41 Patient
A10	Experiencer T42 Patient
A11	Experiencer T43 Patient
A12	Experiencer T45 Patient
A13	Experiencer T46 Patient
A14	Experiencer T48 Patient
A15	Experiencer T51 Patient
